President Trump has signed into law S 920, the National Clinical Care Commission Act, which establishes a national clinical care commission to improve coordination of federal programs that support care for people with complex metabolic syndromes and related autoimmune disorders.
In addition, President Trump signed HR 304, Protecting Patient Access to Emergency Medications Act of 2017. The measure clarifies that emergency medical services professionals may administer controlled substances pursuant to standing or verbal orders in certain circumstances.
This article is presented for informational purposes only and is not intended to constitute legal advice.
